-
-
Specifications
-
Kit Contents
-
References
-
Documentation
|
Application(s)
|
|
Cardiovascular
|
|
Analyte(s)
|
|
FGF (basic), PlGF, Tie-2, VEGF-A, VEGF-C, VEGF-D, VEGFR-1/Flt-1
|
|
Usage Statement
|
|
For Research Use Only. Not for use in diagnostic procedures.
|
|
Storage Condition
|
|
≤-70°C
|
|
|
Product Description
|
Storage
|
Quantity per Kit
|
|
Angiogenesis Control 1
|
≤-70°C
|
5 vial
(NA vial)
|
|
|
|
Angiogenesis Control 2
|
≤-70°C
|
5 vial
(NA vial)
|
|
|
|
Angiogenesis Control 3
|
≤-70°C
|
5 vial
(NA vial)
|
|
|
|
Title
|
Journal
|
Year
|
|
A multi-biomarker score measures rheumatoid arthritis disease activity in the BeSt study.
|
|
|
|
A phase II and biomarker study of ramucirumab, a human monoclonal antibody targeting the VEGF receptor-2 in patients with advanced hepatocellular cancer.
|
|
|
|
Efficacy and safety of mavrilimumab in subjects with rheumatoid arthritis.
|
|
|
|
Elevated sputum Interleukin-5 and submucosal eosinophilia in obese severe asthmatics.
|
|
|
|
Experimental pain and opioid analgesia in volunteers at high risk for obstructive sleep apnea
|
|
|
|
|
View All
|
|
Product Inserts
|
|
|
|
Certificate of analysis
|
|
|
Order Details
Catalog No
Size
Price in USD
Qty
Customer Service/Orders
Scientific/Technical Support
Instrument Support
Company Headquarters